Lung cancer in never-smokers

European Respiratory Journal

Volumn 45, Issue 5, 2015, Pages 1214-1217

  Planchard, David ^a   Besse, Benjamin ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; ORGANIC SOLVENT; SILICON DIOXIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; PASSIVE SMOKING; PROTEIN P21; PROTEIN TYROSINE KINASE;

CANCER MORTALITY; CANCER RISK; DUST; ENVIRONMENTAL EXPOSURE; EPIGENETICS; FUME; GENDER; GENE MUTATION; GENE REARRANGEMENT; GENETIC ASSOCIATION; GENOTOXICITY; HIGH RISK POPULATION; HUMAN; LONG TERM EXPOSURE; NON SMALL CELL LUNG CANCER; OCCUPATIONAL EXPOSURE; PASSIVE SMOKING; PRIORITY JOURNAL; REVIEW; FEMALE; GENETICS; LUNG NEOPLASMS; MALE;

FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PROTO-ONCOGENE PROTEINS P21(RAS); RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TOBACCO SMOKE POLLUTION;

EID: 84929000804     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00046915     Document Type: Review

References (34)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Thun MJ, Hannan LM, Adams-Campbell LL, et al. Lung cancer occurrence in never-smokers: An analysis of 13 cohorts and 22 cancer registry studies. PLoS Med 2008; 5: E185.
3. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers-a different disease. Nature Rev Cancer 2007; 7: 778-790.
4. Toh CK, Gao F, Lim WT, et al. Never-smokers with lung cancer: Epidemiologic evidence of a distinct disease entity. J Clin Oncol 2006; 24: 2245-2251.
5. Subramanian J, Govindan R. Lung cancer in never smokers: A review. J Clin Oncol 2007; 25: 561-570.
6. Alberg AJ, Brock MV, Ford JG, et al. Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143: Suppl. 5, e1s-e29s.
7. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ 1997; 315: 980-988.
8. Darby S, Hill D, Auvinen A, et al. Radon in homes and risk of lung cancer: Collaborative analysis of individual data from 13 European case-control studies. BMJ 2005; 330: 223.
9. Samet JM, Avila-Tang E, Boffetta P, et al. Lung cancer in never smokers: Clinical epidemiology and environmental risk factors. Clin Cancer Res 2009; 15: 5626-5645.
10. Straif K, Benbrahim-Tallaa L, Baan R, et al. A review of human carcinogens-Part C: Metals, arsenic, dusts, and fibres. Lancet Oncol 2009; 10: 453-454.
11. Olsson AC, Gustavsson P, Kromhout H, et al. Exposure to diesel motor exhaust and lung cancer risk in a pooled analysis from case-control studies in Europe and Canada. Am J Respir Crit Care Med 2011; 183: 941-948.
12. Couraud S, Souquet PJ, Paris C, et al. BioCAST/IFCT-1002: Epidemiological and molecular features of lung cancer in never-smokers. Eur Respir J 2015; 45: 1403-1414.
13. Gazdar AF, Thun MJ. Lung cancer, smoke exposure, and sex. J Clin Oncol 2007; 25: 469-471.
14. Toyooka S, Matsuo K, Shigematsu H, et al. The impact of sex and smoking status on the mutational spectrum of epidermal growth factor receptor gene in non small cell lung cancer. Clin Cancer Res 2007; 13: 5763-5768.
15. Vineis P, Alavanja M, Buffler P, et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 2004; 96: 99-106.
16. Zeka A, Mannetje A, Zaridze D, et al. Lung cancer and occupation in nonsmokers: A multicenter case-control study in Europe. Epidemiology 2006; 17: 615-623.
17. Pao W, Girard N. New driver mutations in non-small-cell lung cancer. Lancet Oncol 2011; 12: 175-180.
18. Clinical Lung Cancer Genome Project, Network Genomic Medicine. A genomics-based classification of human lung tumors. Sci Transl Med 2013; 5: 209ra153.
19. Kim HR, Shim HS, Chung JH, et al. Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement. Cancer 2012; 118: 729-739.
20. Barlesi F, Blons H, Beau-Faller M, et al. Biomarkers (BM) France: Results of routine EGFR, HER2, KRAS, BRAF, PI3KCA mutations detection and EML4-ALK gene fusion assessment on the first 10, 000 non-small cell lung cancer (NSCLC) patients ( pts). J Clin Oncol 2013; 31: suppl., 8000.
21. Kris MG, Johnson BE, Berry LD, et al. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA 2014; 311: 1998-2006.
22. Bergethon K, Shaw AT, Ou SH, et al. ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol 2012; 30: 863-870.
23. Lipson D, Capelletti M, Yelensky R, et al. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med 2012; 18: 382-384.
24. Vaishnavi A, Capelletti M, Le AT, et al. Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer. Nat Med 2013; 19: 1469-1472.
25. Couraud S, Vaca-Paniagua F, Villar S, et al. Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: A proof-of-concept study from BioCAST/IFCT-1002. Clin Cancer Res 2014; 20: 4613-4624.
26. Dogan S, Shen R, Ang DC, et al. Molecular epidemiology of EGFR and KRAS mutations in 3, 026 lung adenocarcinomas: Higher susceptibility of women to smoking-related KRAS-mutant cancers. Clin Cancer Res 2012; 18: 6169-6177.
27. Couraud S, Debieuvre D, Moreau L, et al. No impact of passive smoke on the somatic profile of lung cancers in never-smokers. Eur Respir J 2015; 45: 1415-1425.
28. Tam IY, Chung LP, Suen WS, et al. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clin Cancer Res 2006; 12: 1647-1653.
29. Lee YJ, Cho BC, Jee SH, et al. Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer. J Clin Oncol 2010; 28: 487-492.
30. Taga M, Mechanic LE, Hagiwara N, et al. EGFR somatic mutations in lung tumors: radon exposure and passive smoking in former- And never-smoking U.S. women. Cancer Epidemiol Biomarkers Prev 2012; 21: 988-992.
31. Kubo A, Ando M, Soo R, et al. Impact of environmental tobacco smoke (ETS) on ALK rearrangements in never smokers (NS) with non-small cell lung cancer (NSCLC): Analyses on a prospective multinational ETS registry. J Clin Oncol 2013; 31: suppl., 7565.
32. Kawaguchi T, Ando M, Kubo A, et al. Long exposure of environmental tobacco smoke associated with activating EGFR mutations in never-smokers with non-small cell lung cancer. Clin Cancer Res 2011; 17: 39-45.
33. Husgafvel-Pursiainen K, Boffetta P, Kannio A, et al. p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer. Cancer Res 2000; 60: 2906-2911.
34. Collier AC, Dandge SD, Woodrow JE, et al. Differences in DNA-damage in non-smoking men and women exposed to environmental tobacco smoke (ETS). Toxicol Lett 2005; 158: 10-19.